The growing demand for nucleic acid amplification testing (NAAT) is primarily fueled by the increasing prevalence of infectious and genetic diseases. Additionally, this demand is reinforced by the ...

Jim Cramer was recently asked about Danaher Corporation (NYSE:DHR) on CNBC. Cramer praised the company’s management and said ...

Thermo Fisher Scientific is buying Solventum’s purification & filtration unit for $4.1 billion in cash, strengthening its ...

AbbVie, Danaher, Organovo, Thermo Fisher Scientific, and Vertex Pharmaceuticals are the five Biotech stocks to watch today, according to MarketBeat’s stock screener tool. Biotech stocks are shares of ...

The young scientists who place today in the senior division will move on to compete at the Texas State Science and ...

But the man known as "The Easton Assassin," after his hometown, has been a champion in the community too. St. Luke's ...

Thermo Fisher Scientific is expanding its life sciences portfolio by acquiring a division of Solventum that provides ...

Shares of Thermo Fisher Scientific Inc. TMO slid 1.16% to $533.29 Wednesday, on what proved to be an all-around mixed trading ...

GlobalData analyst Dr Andrew S Thompson expects the deal to prompt a "shuffle" in Thermo Fisher’s life sciences unit.

Activist investor Nelson Peltz's Trian Fund Management plans to push Solventum for further business separations following the company's $4.1 billion filtration unit sale, the Wall Street Journal ...

Thermo Fisher Scientific has a market capitalization of about $203.5 billion. Shares (NYSE: TMO) at midday Wednesday were trading around $532, which is near the bottom of their 52-week range.

For the quarter ended December 31, 2024, the SMA outperformed the Index on a gross-of-fees basis due to favorable stock ...